| Document |
Document Title |
|
WO/2021/002195A1 |
The present invention addresses the problem of providing a practical means for producing cysteine from glutathione, said means being suited for use in the field of foodstuffs. The present invention produces cysteine from glutathione usin...
|
|
WO/2020/262860A1 |
The present invention relates to a method for increasing the content of tryptophan in bean sprouts by using a plant elicitor, and extracting the tryptophan therefrom and, more particularly, to a method for building up tryptophan as a use...
|
|
WO/2020/263722A1 |
The present strains and methods relate to yeast cells that over-overproduce selected endogenous proteins having a high amino acid content of a selected amino acid. The yeast can be used in a conventional bioethanol production facility to...
|
|
WO/2020/263732A1 |
Described are compositions and methods relating to yeast having a genetic mutation that results in decreased amounts of Cdc42 effector proteins, resulting in increased alcohol and lysine production. Such yeast is well-suited for use comm...
|
|
WO/2020/263041A1 |
The present application relates to a method for producing a sulfur-containing amino acid or a sulfur-containing amino acid derivative.
|
|
WO/2020/263043A1 |
The present application relates to a method for producing a sulfur-bearing amino acid or a sulfur-bearing amino acid derivative.
|
|
WO/2020/254699A1 |
The present invention relates to a method for municipal solid waste (MSW) reclamation in a continuous or discontinuous process, first for converting said waste into organic biomass and subsequently extracting and recovering as many of th...
|
|
WO/2020/256415A1 |
The present invention relates to microorganisms for producing L-tyrosine, including a gene for encoding a trp operon regulatory region and a prephenate dehydratase operably linked thereto, and a method for producing L-tyrosine by using t...
|
|
WO/2020/232063A8 |
Disclosed herein are synergistic compositions and methods using arginine-producing bacteria and/or ammonia-consuming bacteria in combination with a checkpoint inhibitor for use in treating cancer.
|
|
WO/2020/249616A1 |
A method of upregulating the synthesis of pyruvate and/or a metabolite of pyruvate in a photosynthetic microorganism, a method for the photosynthetic production of a one, two, three or four carbon compounds, and a method for the producti...
|
|
WO/2020/244380A1 |
Provided is a means of knocking out the glnR gene by means of homologous recombination, and a method and application thereof for obtaining a Lactobacillus brevis glnR knockout strain to improve the ability of Lactobacillus brevis γ-amin...
|
|
WO/2020/237701A1 |
Provided are a high-yield L-histidine genetically engineered bacterium strain, and a construction method therefor and an application thereof, integrating a corynebacterium glutamicum ATP phosphoribosyl transferase HisG mutant encoding ge...
|
|
WO/2020/237552A1 |
Provided are a transaminase mutant and a method for producing chiral amines using the transaminase mutant. The amino acid sequence of the transaminase mutant is an amino acid sequence obtained after mutation occurs to the amino acid sequ...
|
|
WO/2020/232519A1 |
The present invention describes the composition of an animal feed additive containing a nutrient-rich fermented broth obtained by means of a fermentation process using a genetically modified microorganism. The non-pathogenic bacterium Co...
|
|
WO/2020/233451A1 |
Disclosed in the present invention is an L-glutamate dehydrogenase mutant, the sequence of the L-glutamate dehydrogenase mutant being a sequence in which amino acid residue A at position 175 in SEQ ID NO. 1 is mutated to be G, and amino ...
|
|
WO/2020/230044A1 |
The present invention relates to a process for preparing an extract with antimicrobial activity from by-products or waste products of the fruit and vegetable industry. The process comprises a step of mixing the by-products or waste produ...
|
|
WO/2020/231426A1 |
Modified host cell and cyanobacterial cells that are capable of producing various mycosporine-like amino acids (MAAs), useful as natural UV absorbing compound, are described.
|
|
WO/2020/232063A1 |
Disclosed herein are synergistic compositions and methods using arginine -producing bacteria and/or ammonia-consuming bacteria in combination with a checkpoint inhibitor for use in treating cancer.
|
|
WO/2020/226341A1 |
The present application relates to a microorganism producing L-amino acid or a precursor thereof and a method for producing L-amino acid or a precursor thereof by using the microorganism.
|
|
WO/2020/218736A1 |
The present application relates to a microorganism with enhanced L-histidine production capacity and a method for producing histidine by using same.
|
|
WO/2020/219859A1 |
Disclosed are trans-enoyl CoA reductase (TER) enzymes and nucleic acids encoding them. In some cases, the TER enzymes are non- natural, engineered trans-enoyl CoA reductase. TER enzymes were shown to catalyse the conversion of 5-carboxy-...
|
|
WO/2020/219866A1 |
Disclosed are transaminase (TA) enzymes and nucleic acids encoding them. In some cases, the transaminase enzymes are non-natural, engineered transaminases. Also disclosed are biosynthetic methods and engineered microorganisms that enhanc...
|
|
WO/2020/218624A1 |
The present invention addresses the problem of providing a method for more easily and highly efficiently industrially producing high-purity L-cyclic amino acids from cyclic amino acids that have a double bond at the 1 position. According...
|
|
WO/2020/218737A1 |
The present application relates to a microorganism with enhanced L-threonine production capacity, and a production method using same.
|
|
WO/2020/219863A1 |
Disclosed are biosynthetic methods and engineered microorganism that enhance or improve the biosynthesis of hexamethylenediamine, caproic acid or caprolactam. The engineered microorganisms include selected aldehyde dehydrogenase activity.
|
|
WO/2020/213447A1 |
The purpose of the present invention is to provide a gardenia blue pigment which offers a bright, fresh blue color tone having reduced redness, and a production method for the same. The gardenia blue pigment which offers a bright, fres...
|
|
WO/2020/213132A1 |
A method for producing a plasmalogen-containing functional material, said method comprising an enzymatic treatment step for treating an animal tissue containing plasmalogen with a protease, and an extraction step for extracting the prote...
|
|
WO/2020/214940A1 |
Described herein are enzymes, such as for example, methanol dehydrogenase (MDH), 3-hexulose-6-phosphate isomerase (PHI), 3-hexulose-6-phosphate synthase (HPS), ribose-5-phosphate isomerase (RPI), ribulose 5-phosphate 3-epimerase (RPE), t...
|
|
WO/2020/208842A1 |
The present disclosure pertains to a genetically modified microorganism that satisfies some of specific requirements. The specific requirements include: (I) compared to a wild type microorganism, having reduced or inactivated succinate d...
|
|
WO/2020/204179A1 |
A method is described for producing an L-amino acid including the steps of cultivating in a culture medium an L-amino acid-producing bacterium belonging to the family Enterobacteriaceae to produce and accumulate the L-amino acid in the c...
|
|
WO/2020/204427A1 |
The present application relates to a protein variant having tryptophan export activity, a microorganism producing L-tryptophan and expressing the protein variant, and a method for producing L-tryptophan using the microorganism.
|
|
WO/2020/198258A1 |
The present disclosure describes the engineering of microbial cells for fermentative production of L-homocysteine and provides novel engineered microbial cells and cultures, as well as related L-homocysteine production methods.
|
|
WO/2020/196619A1 |
The present invention can produce an L-amino acid oxidase at a low cost and in a large quantity through a high expression of a recombinant protein, and the like, and provides a novel L-amino acid oxidase (ArtLAAO) having a wide substrate...
|
|
WO/2020/187271A1 |
Provided is a dual-plasmid system comprising a first plasmid for an expression cassette for expressing a target protein containing a predetermined modified amino acid, a second plasmid for an expression cassette for expressing aminoacyl-...
|
|
WO/2019/164346A8 |
The present application relates to a Corynebacterium sp. microorganism for producing L-tryptophan by using a gene manipulation technique and a method for producing L-tryptophan by using the microorganism.
|
|
WO/2020/067618A8 |
The present application relates to an L-amino acid-producing microorganism exhibiting reinforced α-glucosidase activity, and an L-amino acid production method using same. The L-amino acid-producing Corynebacterium sp. microorganism, acc...
|
|
WO/2020/187256A1 |
Provided is a method for preparing β-alanine, the method comprising: preparing a β-alanine product from a reactant containing fumaric acid and aqueous ammonia in the presence of a catalyst, wherein the catalyst contains a catalyst comp...
|
|
WO/2020/181779A1 |
A method for preparing a lipoamino acid compound on the basis of a deep eutectic solvent, which relates to the field of organic synthesis. A fatty acid and an amino acid are used as substrates and a deep eutectic solvent is used as a med...
|
|
WO/2020/183033A1 |
The invention provides a fertiliser composition that includes an enhancer of nitrogen that can be assimilated by plants, the enhancer of assimilable nitrogen being tyramine, a combination of the fertiliser composition together with other...
|
|
WO/2020/174101A1 |
Biological solid state fermentation process The invention provides a biological solid state fermentation process wherein an animal residual raw material having a proteic nitrogen content of high value for different industrial processes, ...
|
|
WO/2020/152104A3 |
The invention is directed to methods for the production of 4-cyano benzoic acid or salts thereof from terephthalonitrile using nitrilase as catalyst and compositions comprising 4-cyano benzoic acid.
|
|
WO/2020/171227A1 |
The present invention provides a method for producing L-amino acids by fermentation using a bacterium belonging to the family Enterobacteriaceae which has been modified to overexpress ydiJ gene.
|
|
WO/2020/163935A1 |
The present invention provides biochemical pathways, glyoxylate producing recombinant microorganisms, and methods for the production and yield improvement of glycolic acid and/or glycine via a reverse glyoxylate shunt. The reverse glyoxy...
|
|
WO/2020/155690A1 |
Provided is a system for efficiently catalyzing an aliphatic dinitrile hydration reaction using a new nitrile hydratase. Provided is the brand-new use of nitrile hydratase from Rhodococcus erythropolis CCM2595 in the catalysis of aliphat...
|
|
WO/2020/152104A2 |
The invention is directed to methods for the production of 4-cyano benzoic acid or salts thereof from terephthalonitrile using nitrilase as catalyst and compositions comprising 4-cyano benzoic acid.
|
|
WO/2020/150125A1 |
The present invention provides engineered transaminase polypeptides and compositions thereof, as well as polynucleotides encoding the engineered transaminase polypeptides. Methods for producing transaminase enzymes are also provided. In ...
|
|
WO/2020/147031A1 |
Disclosed are a nitrile hydratase mutant, a genetically engineered bacterium containing the mutant, and the use thereof, falling within the technical field of enzyme engineering. According to the present invention, glycine at position 47...
|
|
WO/2020/081958A3 |
Embodiments of the present disclosure provide for generating engineered microorganisms for increased tolerance and/or production of a target molecule. In certain embodiments, a microorganism is Escherichia coli (E. coli). In some embodim...
|
|
WO/2020/146587A1 |
Compositions for improving the bioavailability of methionine. In general, the compositions comprise a source of methionine and essential oil(s). More specifically, the compositions comprise a source of methionine and a plurality of coate...
|
|
WO/2020/144371A1 |
The present invention relates to a recombinant microbial host cell comprising an operative biosynthetic metabolic pathway capable of producing one or more compounds selected from the group consisting of L-dopa, dopamine, (S)-Norcoclaurin...
|
